VTP-38543

· Vitae Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VTP-38543, covering 2019-02-15 to 2019-02-15. Get the full timeline:

Most recent: Clinical Trial Update: An Ascending Multiple Dose Study of VTP-38543 in Adult Participants With Mild to Moderate Atopic Dermatitis [Phase 1, Phase 2]

See pricing